1921
Volume 2, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

In recent investigations Eyles and Coleman (1952) demonstrated that 2,4-diamino-5-p-chlorophenyl-6-ethylpyrimidine (Daraprim) prevented death of white mice experimentally infected with a strain of isolated from the Norway rat. Additional studies by Eyles (1953) showed that the antitoxoplasmal action of Daraprim was enhanced by sulfadiazine.

In experimental toxoplasmosis it is well known that chemotherapy with such agents as sulfonamides, sulfones and certain antibiotics may prevent death of mice during the period of drug administration. It has been repeatedly observed however that may not be eradicated from the tissues of mice and that relapse and death may occur within a variable time following cessation of therapy. It has been observed here that treated mice may survive for several months or possibly for the duration of their normal life span yet retaining foci of virulent in their tissues. It is questionable therefore whether survival of -infected mice during the period of experimental chemotherapy constitutes a valid criterion of drug efficacy.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1953.2.1037
1953-11-01
2017-11-17
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1953.2.1037
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error